ArticleFrontiers in medical technology2026
Mamba-ADR: adverse drug reaction detection from social-media using state-space regression model.
Article in Frontiers in medical technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug adverse reactions (ADRs) is vital to minimize health risks and reduce drug development costs. Extracting ADRs (ADRE) from social media is a vital supplement to conventional pharmacovigilance databases. However, it remains particularly challenging due to the informal and noisy nature of usergenerated content. It combines the state space model with the convolutional module to efficiently capture long-range dependencies and extract more discriminative features, while completing the recognition and quantification of ADRs through a regression module. Experiments on the MedHelp Medical Forum dataset demonstrates that Mamba-ADR has a low computational complexity and an accuracy rate of 78.1%, and is superior to the state-of-the art methods. It provides a promising tool for ADRE in in drug discovery and development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.